NIPT Market Will Boost Global Value during 2019-2026
Non-Invasive Prenatal Testing (NIPT) Market
Outlook 2019-2026:
Global Non-Invasive
Prenatal Testing (NIPT) Market key players are Ge Healthcare (General
Electric Company), Koninklijke Philips N.V., Illumina, Inc., Thermo Fisher
Scientific, Inc., F. Hoffman-La Roche Ltd., Pacific Biosciences of California,
Inc., Perkinelmer, Inc., Qiagen N.V., Agilent Technologies, Inc., and Beijing
Genomics Institute.
Non-invasive prenatal testing is also known as
non-invasive parenteral screening, which is a nascent genetic process of
examining a fetal cell free DNA present in the mothers blood serum for
detecting common fetal aneuploidies. Its main objective is early detection of
genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward
syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It
can also detect the blood group and rhesus actor of the fetus. Some of the
NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama,
NIFTY, PrenaTest, BambniTest, and others.
Download Sample Copy of this Report at: https://www.alliedmarketresearch.com/request-toc-and-sample/2706
Growth in reimbursements for the NIPT sector,
increased shift from invasive methods to non-invasive methods, and growth of
maternal age (associated with growth in the risk of chromosomal abnormalities
in babies) drive the market. In addition, launch and development of advanced
and new technologies and non-invasive parenteral testing products also fuels
the market growth. However, lack of skilled professionals as well as strict
regulatory guidelines and ethical hurdles slow down the process of approvals
and marketing, thus restricting the market growth. Untapped emergence of new
market in Asia-Pacific make way for growth opportunities for his market.
The report segments the market on the basis of
product, method, application, end users, and region. Based on product, it is
bifurcated into consumables and instruments. Based on method, it is divided
into ultrasound detection, biochemical screening tests, cell-free DNA in
maternal plasma tests, and fetal cells in maternal blood tests. Based on
application, it can be categorized into trisomy, microdeletion syndrome, and
other applications. By geography, the market is studied across North America,
Europe, Asia-Pacific, and LAMEA.
First time buyer? Check offers and discount on
this report: https://www.alliedmarketresearch.com/purchase-enquiry/2706
Key Benefits
- The study provides an in-depth analysis of the non-invasive prenatal testing market, with current trends and future estimations to elucidate the imminent investment pockets.
- It presents a quantitative analysis from 2016 to 2023
to enable the stakeholders to capitalize on prevailing market
opportunities.
- Extensive analysis of the market by product type
elucidates various forms of non-invasive prenatal testing available.
- Key players are profiled and their strategies are
analyzed thoroughly, which predict the competitive outlook of the market.
Source Medium: https://medium.com/@evanacook727/non-invasive-prenatal-testing-nipt-market-is-expected-to-boom-worldwide-by-2026-771cfd6b6b5a
Comments
Post a Comment